Compare Mounjaro vs Wegovy vs Saxenda

Side-by-side comparison of the UK's three leading weight loss injection medications. All data from peer-reviewed clinical trials.

Weight Loss Medication Comparison Table

All clinical data sourced from the landmark trials for each medication. Prices reflect current UK private pharmacy rates as of February 2026.

FeatureMounjaroWegovySaxenda
Active IngredientTirzepatideSemaglutideLiraglutide
ManufacturerEli LillyNovo NordiskNovo Nordisk
MechanismDual GIP + GLP-1GLP-1 onlyGLP-1 only
Injection FrequencyOnce weeklyOnce weeklyOnce daily
Average Weight Loss22.5% (15mg)¹14.9% (2.4mg)²8.0% (3mg)³
Trial Duration72 weeks68 weeks56 weeks
Starting Price (UK)From £149/monthFrom £155/monthFrom £155/month
Dose Range2.5–15mg0.25–2.4mg0.6–3.0mg
Escalation Period~20 weeks~16 weeks~5 weeks
NICE ApprovedYes (TA924)Yes (TA875)Yes (TA664)
NHS AvailableLimitedLimitedLimited
Pancreatitis RiskSmall risk⁴Small risk⁴Small risk⁴

Key Differences

Mounjaro — Most Effective

With an average weight loss of 22.5% in clinical trials, Mounjaro is the most effective option currently available. Its dual GIP/GLP-1 mechanism sets it apart from Wegovy and Saxenda, which target only the GLP-1 receptor.¹

Wegovy — Proven Track Record

Wegovy was the first GLP-1 to gain NICE approval for weight management and has extensive real-world evidence. At 14.9% average weight loss, it sits between Mounjaro and Saxenda in terms of effectiveness.²

Saxenda — Fastest Escalation

Saxenda reaches its full dose in just 5 weeks (vs 16–20 for Wegovy/Mounjaro), but requires daily injections rather than weekly. At 8.0% average weight loss, it is less effective but may suit patients who cannot tolerate the newer medications.³

Read the Full Guides

Ready to Get Started?

Compare prices from verified UK pharmacies for Mounjaro, Wegovy, and Saxenda.

Important Medical Information

This website provides general information about weight loss medications for educational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult your GP or qualified healthcare professional before starting any weight loss medication. Individual results may vary.

WhichWeightMeds.org is an independent comparison platform and is not affiliated with any pharmacy, manufacturer, or healthcare provider. We do not prescribe, sell, or dispense medications.

Sources & References

  1. 1
    SURMOUNT-1 (Tirzepatide)NEJM, 2022 (Accessed February 2026)View source
  2. 2
    STEP 1 (Semaglutide)NEJM, 2021 (Accessed February 2026)View source
  3. 3
    SCALE (Liraglutide)NEJM, 2015 (Accessed February 2026)View source
  4. 4
    GLP-1 receptor agonists safety reviewMHRA (Accessed February 2026)View source